Search for: "Teva Branded Pharmaceutical Products R" Results 1 - 20 of 94
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Sep 2012, 9:59 pm by Patent Docs
Teva Branded Pharmaceutical Products R&D Inc. et al. v. [read post]
25 Sep 2008, 4:23 am
According to Teva's release, the company's G-CSF product, which will be marketed in Europe under the brand name TevaGrastim ® beginning in 2009, is the first G-CSF biosimilar to receive a marketing authorization in the EU.... [read post]
28 Dec 2017, 2:44 am by Neil Wilkof
How to right the ship with respect to its generic products, while also ramping up the necessary R&D to support a viable proprietary drug business, is daunting for even the largest pharmaceutical company. [read post]
3 May 2011, 6:00 am
The move will help Teva offset revenue it may lose as its multiple-sclerosis drug Copaxone faces competition from generic versions and new branded products. [read post]
13 Oct 2012, 3:30 pm
Teva Pharmaceutical Industries Ltd makes this generic drug as well as many other generic drugs. [read post]
9 May 2013, 5:34 am
The lawsuit names Pfizer, as well as two different generic drug manufacturers - Actavis Elizabeth and Teva Pharmaceuticals - in the U.S. [read post]
16 Jun 2015, 6:00 am
Teva Pharmaceutical Industries, Ltd. will make a total of $1.2B available to compensate purchasers, including drug wholesalers, pharmacies, and insurers, who overpaid because of Cephalon’s illegal conduct. [read post]
15 May 2019, 5:27 am by Kluwer Patent blogger
Kluwer Patent blogger44 U.S. states filed a lawsuit last Friday accusing Teva Pharmaceuticals USA of conspiring illegally with 19 other drug companies to inflate drug prices – sometimes by more than 1,000 percent – and stifle competition for generic drugs. [read post]
The Hatch-Waxman Act allows the FDA to permit a generic version of a branded product, which is partially patent protected, to come to market if the generic manufacturer “carves out” the patent-protected indication from its label. [read post]
17 Jun 2011, 2:25 am
The Bedford Report keeps an eye on healthcare companies and provides research reports on Teva Pharmaceutical Industries Limited (makers of generic Yasmin) and Mylan Inc., the makers of Effexor. [read post]
25 Oct 2011, 9:28 am by Jenna Greene
Court of Appeals for the 2nd Circuit that found a pay for delay deal between Bayer AG and Barr Pharmaceuticals (now owned by Teva Pharmaceuticals) to drop a patent lawsuit over the antibiotic Cipro did not violate antitrust laws. [read post]
5 May 2014, 8:28 am by Gene Quinn
Unfortunately for Actavis, on April 28, 2014, the FDA awarded sole exclusivity on generic Celebrex® to Teva Pharmaceutical Industries Ltd. [read post]
13 Feb 2015, 12:00 pm by Greene LLP
AstraZeneca markets and sells pharmaceutical products in the United States, including a drug sold under the trade name Nexium. [read post]